We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$177M |
| 2 |
Lowe's Companies
LOW
|
+$108M |
| 3 |
STJ
St Jude Medical
STJ
|
+$95.4M |
| 4 |
Newell Brands
NWL
|
+$88.6M |
| 5 |
Constellation Brands
STZ
|
+$87.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$136M |
| 2 |
UnitedHealth
UNH
|
+$99.3M |
| 3 |
PayPal
PYPL
|
+$85.4M |
| 4 |
Starbucks
SBUX
|
+$78.1M |
| 5 |
Cigna
CI
|
+$64.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Consumer Discretionary | 12.48% |
| 3 | Communication Services | 12.09% |
| 4 | Technology | 9.72% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QVCGA
351
DELISTED
QVC Group Inc Series A
QVCGA
| $6.55M | 0.05% |
6,746
-2,513
| -27% | -$2.77M |
|
|
SCHW
352
Charles Schwab
SCHW
$177B
| $6.55M | 0.05% |
+207,518
| New | +$6.09M |
|
353
Acadia Healthcare
ACHC
$3.17B
| $6.53M | 0.05% |
+131,755
| New | +$6.86M |
|
354
Robert Half
RHI
$3.61B
| $6.51M | 0.05% |
171,883
-18,022
| -9% | -$687K |
|
355
Thor Industries
THO
$3.99B
| $6.51M | 0.05% |
+76,832
| New | +$5.97M |
|
356
Freeport-McMoran
FCX
$90B
| $6.49M | 0.05% |
+597,283
| New | +$6.87M |
|
|
BPL
357
DELISTED
Buckeye Partners, L.P.
BPL
| $6.43M | 0.05% |
89,833
+22,109
| +33% | +$1.57M |
|
358
Cisco
CSCO
$450B
| $6.42M | 0.05% |
+202,556
| New | +$6.23M |
|
|
SINA
359
DELISTED
Sina Corp
SINA
| $6.41M | 0.05% |
86,770
-13,028
| -13% | -$862K |
|
360
Waste Management
WM
$95.9B
| $6.38M | 0.05% |
+100,000
| New | +$6.54M |
|
361
Watsco Inc
WSO
$14.9B
| $6.37M | 0.05% |
45,204
+15,845
| +54% | +$2.27M |
|
362
Helen of Troy
HELE
$663M
| $6.36M | 0.05% |
+73,841
| New | +$6.92M |
|
363
Under Armour Class C
UA
$2.92B
| $6.35M | 0.05% |
187,611
-374,530
| -67% | -$13.5M |
|
364
Amgen
AMGN
$203B
| $6.32M | 0.04% |
37,857
-50,885
| -57% | -$8.6M |
|
365
NVR
NVR
$17.2B
| $6.32M | 0.04% |
+3,851
| New | +$6.56M |
|
366
Golar LNG
GLNG
$4.95B
| $6.24M | 0.04% |
+294,527
| New | +$5.63M |
|
367
Grupo Cibest SA
CIB
$20.4B
| $6.19M | 0.04% |
+158,530
| New | +$5.89M |
|
|
TGP
368
DELISTED
Teekay LNG Partners L.P.
TGP
| $6.17M | 0.04% |
+407,673
| New | +$5.12M |
|
369
Qualcomm
QCOM
$176B
| $6.15M | 0.04% |
89,818
+66,260
| +281% | +$4.03M |
|
370
Vail Resorts
MTN
$5.19B
| $6.14M | 0.04% |
39,170
+11,191
| +40% | +$1.71M |
|
|
CBM
371
DELISTED
Cambrex Corporation
CBM
| $6.09M | 0.04% |
+137,042
| New | +$6.67M |
|
372
Minerva Neurosciences
NERV
$188M
| $6.08M | 0.04% |
53,842
+21,154
| +65% | +$2.05M |
|
373
Red Rock Resorts
RRR
$3.74B
| $6M | 0.04% |
254,502
-676,773
| -73% | -$15.2M |
|
|
ICPT
374
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $6M | 0.04% |
36,468
-72,659
| -67% | -$11.5M |
|
|
ADXS
375
DELISTED
Advaxis Inc
ADXS
| $5.98M | 0.04% |
37,305
+19,065
| +105% | +$3.1M |
|
Similar funds
Marshall Wace's Q3 2016 Portfolio in Review
As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.
- Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
- Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
- Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
- Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
- Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.
Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.